Physician Assistant · Temecula, CA
NPI
1083892236
Since 2008
Specialty
Physician Assistant
Code 390200000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
31700 Temecula Pkwy
Temecula, CA, 92592
Phone (951) 600-4338
Groups this clinician bills Medicare through
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$1.8M
733 prescriptions
Company payments, 2025
$137
From 6 companies
Medicare prescription drug claims, 2024
In 2024, the drug Chris Towery prescribed most often to Medicare patients was Cosentyx Sensoready (2 Pens) (Secukinumab), with 82 prescriptions and refills. In total Chris Towery wrote 733 Medicare prescriptions that cost $1.8M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-01-23.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Cosentyx Sensoready (2 Pens) Secukinumab | 82 | 82 | 14 | $589K |
| Mupirocin Generic | 57 | 57 | 33 | $260 |
| Doxycycline Hyclate Generic | 52 | 54 | 43 | $15K |
| Dupixent Pen Dupilumab | 46 | 46 | Under 11 | $169K |
| Clobetasol Propionate Generic | 38 | 38 | 12 | $1,293 |
| Fluocinonide Generic | 37 | 40 | 22 | $2,229 |
| Cosentyx Unoready Pen Secukinumab | 35 | 35 | Under 11 | $254K |
| Ketoconazole Generic | 33 | 33 | 11 | $390 |
| Mupirocin Mupirocin Calcium | 23 | 23 | 20 | $3,568 |
| Tretinoin Generic | 21 | 21 | Under 11 | $856 |
| Dupixent Syringe Dupilumab | 19 | 19 | Under 11 | $70K |
| Otezla Apremilast | 16 | 16 | Under 11 | $76K |
| Skyrizi Pen Risankizumab-Rzaa | 16 | 41 | Under 11 | $322K |
| Clindamycin-Benzoyl Peroxide Clindamycin Phos/Benzoyl Perox | 13 | 13 | Under 11 | $5,532 |
| Zoryve Roflumilast | 12 | 13 | Under 11 | $9,737 |
Brand drugs: 291 claims; generic drugs: 442 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Chris Towery $137 ($137 in general payments such as food, travel and fees) from 6 companies. The largest payer was Bayer Healthcare Pharmaceuticals Inc. with $32.32.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.